NCT05415956

Brief Summary

Deterioration of walking capacity is a common symptom in persons with multiple sclerosis (pwMS), furthermore having a negative influence on well-being. Studies have nevertheless shown that walking exercise therapy can improve walking capacity in pwMS. This may be particularly potent if occurring outdoors due to the varying stimuli it can provide (different surfaces and terrain etc.), and if the intensity and duration is adequate. Furthermore, outdoor walking is (1) suitable as a group intervention facilitating interaction between pwMS and (2) advantageous due to the health benefits offered through the interaction with nature itself. Both these aspects are also relevant for well-being. Few studies have nevertheless examined the effects of outdoor walking exercise therapy in pwMS. The purpose of the present study is therefore to examine the effects of 7 weeks of moderate-to-high intensity outdoor walking exercise therapy on walking capacity (primary outcome: 6-minute walk test) and well-being in pwMS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

November 25, 2021

Completed
7 months until next milestone

First Posted

Study publicly available on registry

June 13, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

September 1, 2023

Status Verified

November 1, 2021

Enrollment Period

9 months

First QC Date

November 25, 2021

Last Update Submit

August 31, 2023

Conditions

Keywords

ExerciseWalking

Outcome Measures

Primary Outcomes (1)

  • 6-minutes walk test (6MWT)

    Maximal distance covered in 6 minutes using a 30 meter walkway. Assesses walking endurance.

    Change from baseline (Pre) to after 7 weeks intervention (Post)

Secondary Outcomes (19)

  • 6-minutes walk test (6MWT)

    Change from baseline (Pre) to 24 weeks follow-up (Follow-up)

  • Timed 25-foot walk test (T25FWT)

    Change from baseline (Pre) to after 7 weeks intervention (Post)

  • Timed 25-foot walk test (T25FWT)

    Change from baseline (Pre) to 24 weeks follow-up (Follow-up)

  • Six spot step test (SSST)

    Change from baseline (Pre) to after 7 weeks intervention (Post)

  • Six spot step test (SSST)

    Change from baseline (Pre) to 24 weeks follow-up (Follow-up)

  • +14 more secondary outcomes

Study Arms (2)

Walking exercise therapy

EXPERIMENTAL

7 week intervention group. 6-12 persons per group. 2 sessions per week, 14 sessions in total. Surface: the investigators aim to involve as much forest/gravel trails as possible, with up/down hill walking. Uneven session numbers: warm-up (6 minutes at BORG 10-11), continous walking (starting at 12-20 minutes at BORG 13-14 and progressing to 20-40 minutes at BORG 15-16, adjusted according to the starting level of each participant) and cool-down (approximately 10 minutes at BORG 10-11). Even session numbers: warm-up (6 minutes at BORG 10-11), intermittent walking (starting at 3-4 intervals of 2 minutes at BORG 14-15 and progressing to 4-5 intervals of 2-3 minutes at BORG 16-17; with all intervals being interspersed by 1 minute rest) and cool-down (approximately 10 minutes at BORG 10-11).

Behavioral: Walking exercise therapy

Control/Waitlist

NO INTERVENTION

7 week control/waitlist group. Continuation of habitual lifestyle during the 7 week intervention period (yet these participants will receive the exact walking exercise therapy afterwards).

Interventions

Moderate-to-high intensity walking exercise therapy (7 weeks, 14 session) with progression in duration and intensity.

Also known as: Physical exercise
Walking exercise therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years
  • self-reported clinical MS diagnosis
  • PDDS ≤ 4 (corresponding to preserved walking capacity without assistive devices of at least 10 m)
  • able to independently attend the testing

You may not qualify if:

  • self-reported comorbidities excluding participation in the intervention
  • recent (6 months retrospective) fractures, amputation or other critical physical impairments that eliminates participation in the described training study
  • participation in structured exercise therapy (including walking) for the past 3 months (≥ 2 session per week of moderate-to-high intensity)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University, Health, Exercise Biology

Aarhus, Jutland, 8000, Denmark

Location

Related Publications (1)

  • Hvid LG, Steenberg JL, Roy F, Skovgaard L. Outdoor walking exercise therapy improves walking capacity and well-being in persons with multiple sclerosis: A randomized controlled trial. Ann Phys Rehabil Med. 2025 Sep;68(6):101985. doi: 10.1016/j.rehab.2025.101985. Epub 2025 Apr 18.

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Lars G Hvid, MSc, PhD

    Aarhus University, Department of Public Health, Exercise Biology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 7 week randomized controlled trial; intervention group and waitlist/control group. The investigators will perform a cluster randomization (computer generated random numbers) according to cities across Denmark (when 4-12 pwMS are interested and eligible). Waitlist/control group will be offered the same outdoor walking exercise therapy after the initial 7 weeks. 24 weeks after the walking exercise intervention, a follow-up test will be carried out as well.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2021

First Posted

June 13, 2022

Study Start

November 1, 2021

Primary Completion

July 31, 2022

Study Completion

November 30, 2022

Last Updated

September 1, 2023

Record last verified: 2021-11

Locations